Sepsis 2015: You say you wanted a revolution

Similar documents
6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

Guidelines are the Future of Sepsis Management Pro

Why does it matter? Sepsis

Sepsis: Getting to ZERO Probable or Impossible?

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

Sepsis: Identification and Management in an Acute Care Setting

UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center

Early Goal-Directed Therapy

Sepsis. Reliability- can we achieve Dr Ron Daniels

Sepsis Management Update 2014

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Sepsis Management: Past, Present, and Future

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Nothing to disclose 9/25/2017

9/25/2017. Nothing to disclose

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Saving Lives: Focusing on Severe Sepsis and Septic Shock

Sepsis - A Year in Transition

Cardiovascular Management of Septic Shock

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

The Management of Sepsis: What s New in 2013

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

BC Sepsis Network Emergency Department Sepsis Guidelines

SURVIVING SEPSIS: Early Management Saves Lives

Updates in Sepsis 2017

Staging Sepsis for the Emergency Department: Physician

A Critical Review of Early Goal Directed Therapy and Government Endorsement

Surviving Sepsis Campaign update

SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP

Troubleshooting Audio

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

MAKING SENSE OF IT ALL AUGUST 17

Actualités de la prise en charge hémodynamique initiale Daniel De Backer

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

The 2016 Surviving Sepsis Guidelines have arrived, a

Sepsis. From EMS to ER to ICU. What we need to be doing

Sepsis. Current Dilemmas in Diagnosing Sepsis. Chapter 2

Diagnosis and Management of Sepsis. Disclosures

EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer

Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the

Introduction. Centers for Disease Control and Prevention (CDC),

Initial Resuscitation of Sepsis & Septic Shock

Core Measures SEPSIS UPDATES

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Sepsis Wave II Webinar Series. Sepsis Reassessment

Disclosures Paul Walker MD PhD FRCSC

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Sepsis 3.0: The Impact on Quality Improvement Programs

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Sepsis Learning Collaborative: Sepsis New Definitions

Early-goal-directed therapy and protocolised treatment in septic shock

The Surviving Sepsis Campaign: Where have we been and where are we going?

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

How can the PiCCO improve protocolized care?

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

Billion

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

Jarisch A. Kreislauffragen, Dünser et al. Critical Care 2013, 17:326 Sunday, March 30, 14

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Surviving Sepsis Campaign

Steps to Success in Sepsis ASHNHA Quality Webinar. Maryanne Whitney, RN, CNS, MSN Improvement Advisor, Cynosure Health

Sepsis clinical evolution: Understand essential challenges to developing effective queries

Methodological co-investigators

Fluid responsiveness and extravascular lung water

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

John Park, MD Assistant Professor of Medicine

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016

OHSU. Update in Sepsis

towards early goal directed therapy

Dr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia (Spain) Pulsion MAB

Management of Severe Sepsis:

Paramedic Initiated Prehospital CMS Sepsis Core Measures. Jason Walchok NRP, FP-C Training Coordinator, Greenville County EMS

Sepsis care and the new core measures

Prof. Dr. Iman Riad Mohamed Abdel Aal

Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia

Sepsis Awareness and Education

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Prehospital treatment of sepsis Christopher W. Seymour, MD MSc

Polymyxin B Hemoperfusion in Pneumonic Septic Shock Caused by Gram-Negative Bacteria

Inpatient Quality Reporting (IQR) Program

UTILITY of ScvO 2 and LACTATE

Managing Patients with Sepsis

3/14/2017. Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care. Objectives. Developmental Response to Sepsis

Advancements in Sepsis

FLUIDS AND SOLUTIONS IN THE CRITICALLY ILL. Daniel De Backer Department of Intensive Care Erasme University Hospital Brussels, Belgium

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Transcription:

Thomas Jefferson University Jefferson Digital Commons Pulmonary and Critical Care Medicine, Presentations and Grand Rounds Division of Pulmonary and Critical Care Medicine 6-10-2015 Sepsis 2015: You say you wanted a revolution R. Phillip Dellinger, MD, MCCM Professor and Chair, Department of Medicine Cooper Medical School of Rowan University Medical Director, Adult Health Institute Senior Attending, Critical Care Medicine Cooper University Health Care, dellinger-phil@cooperhealth.edu Let us know how access to this document benefits you Follow this and additional works at: http://jdc.jefferson.edu/pulmcritcaregrandrounds Part of the Medicine and Health Sciences Commons Recommended Citation Dellinger, MD, MCCM, R. Phillip, "Sepsis 2015: You say you wanted a revolution" (2015). Pulmonary and Critical Care Medicine, Presentations and Grand Rounds. Presentation 122. http://jdc.jefferson.edu/pulmcritcaregrandrounds/122 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Pulmonary and Critical Care Medicine, Presentations and Grand Rounds by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

SEPSIS 2015: YOU SAY YOU WANT A REVOLUTION R. Phillip Dellinger MD, MSc, MCCM Professor and Chair of Medicine Cooper Medical School of Rowan University Medical Director Adult Health Institute Senior Critical Care Attending Cooper University Hospital Camden NJ USA

POTENTIAL CONFLICTS OF INTEREST Hold leadership position in Surviving Sepsis Campaign Cooper University Hospital receives consultant fees and research funding from Spectral Inc. for work with the EUPHRATES trial.

Burden of Severe Sepsis Sepsis Performance Improvement Revolution Research : New or Ongoing Clinical Trials

Burden of Severe Sepsis

SEVERE SEPSIS Severe Sepsis is the Leading Cause of Hospital Death Admissions with severe sepsis 8X > chance of death than other conditions Most expensive condition treated in the hospital (23 billion dollars per annum) Enormous economic burden that can be lessened with early identification and early appropriate evidence based medicine care NCHS data brief #62, 2011 US National Lib Med, NIH, 2010 HCUP Statistical Brief #160

Causes of death in New Jersey in 2011, according to the most recent data available. New Jersey Department of Health posted January 8, 2015

HEALTHCARE, WE HAVE A PROBLEM.

CURRENTLY FUNDED WITH A GORDON AND BETTY MOORE FOUNDATION GRANT (INTEL FAMILY). NO DIRECT OR INDIRECT INDUSTRY SUPPORT FOR GUIDELINES REVISION

SURVIVING SEPSIS CAMPAIGN: INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC SHOCK: 2012 R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan E. Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark E. Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth M. Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flavia R. Machado,Gordon D. Rubenfeld, Steven A. Webb, Richard J. Beale, Jean-Louis Vincent, Rui Moreno, and the Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Crit Care Med 2013; 41:580-637 Intensive Care Medicine 2013; 39: 165-228

CURRENT SURVIVING SEPSIS CAMPAIGN GUIDELINE SPONSORS American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians Australian and New Zealand Intensive Care Society Asia Pacific Association of Critical Care Medicine American Thoracic Society Brazilian Society of Critical Care(AIMB) Canadian Critical Care Society Chinese Society of Critical Care Medicine Emirates Intensive Care Society European Respiratory Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Society of Pediatric and Neonatal Intensive Care Infectious Diseases Society of America Indian Society of Critical Care Medicine International Pan Arab Critical Care Medicine Society Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Pediatric Acute Lung Injury and Sepsis Investigators Society Academic Emergency Medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society World Federation of Critical Care Nurses World Federation of Pediatric Intensive and Critical Care Societies World Federation of Societies of Intensive and Critical Care Medicine Participation and endorsement: German Sepsis Society Latin American Sepsis Institute

GUIDELINES ARE NOT ENOUGH Protocols Performance Improvement Programs Audit and Feedback

Early Screening and a Hospital Based Performance Improvement Program

GUIDELINES TO BUNDLES

CONVERTING GOALS TO MEASURABLE INDICATORS

CHANGE IN COMPLIANCE OVER TIME Levy MM, Dellinger, RP, Townsend SA et al. CCM 38(2):367-374, February 2010.

CHANGE IN MORTALITY OVER TIME Levy MM, Dellinger, RP, Townsend SA et al. CCM 38(2):367-374, February 2010.

Levy, et al. Crit Care Med. 2015 Jan;43(1):3-12.

SSC MORTALITY Levy, et al. Crit Care Med. 2015 Jan;43(1):3-12.

WHY?

Levy, et al. Crit Care Med. 2015 Jan;43(1):3-12.

INITIAL RESUSCITATION OF SEPSIS INDUCED TISSUE HYPOPERFUSION Recommend Insertion central venous catheter Recommended goals : Central venous pressure: 8 12 mm Hg Higher with altered ventricular compliance or increased intrathoracic pressure ScvO2 saturation (SVC) 70% Grade 1C

STARLING PRINCIPLE RELATES TO VOLUME The Starling principle relates to the fact that the more a myocardial fibril is stretched the greater the contraction.

EXPECTED RESULT OF VOLUME EXPANSION

CENTRAL VENOUS PRESSURE POORLY PREDICTS CARDIAC PRELOAD AND VOLUME STATUS Michard F, et al. Chest 2002; 121:2000 2008. Kumar A, et al. Crit Care Med 2004; 32:691 699. Shippy CR, et al. Crit Care Med 1984; 12:107 112.

INTRAVASCULAR VOLUME STATUS AND PERFUSION PARAMETERS Limitation of pressure measurement to predict fluid responsiveness There are alternatives to CVP for judging fluid responsiveness that are in general more reliable

ARTERIAL SYSTOLIC PRESSURE VARIATION Parry-Jones, et al. Int J Respir Crit Care Med 2003;2:67

EFFECT ON CARDIAC FILLING

EFFECT ON STROKE VOLUME P art A t

EFFECT ON STROKE VOLUME

You say you want a revolution Revolution

NATIONAL QUALITY FORUM 2012 NQF: SEPSIS 0500 TO BE COMPLETED WITHIN 3 HOURS OF TIME OF PRESENTATION : 1. Measure lactate level 2. Obtain blood cultures prior to administration of antibiotics 3. Administer broad spectrum antibiotics 4. Administer 30ml/kg crystalloid for hypotension or lactate 4mmol/L

2012 NQF: SEPSIS 0500 TO BE COMPLETED WITHIN 6 HOURS OF TIME OF PRESENTATION: 5. Apply vasopressors (for hypotension that does not respond to initial fluid resuscitation to maintain a mean arterial pressure (MAP) 65mmHg) 6. In the event of persistent arterial hypotension despite volume resuscitation (septic shock) or initial lactate 4 mmol/l (36mg/dl): - Measure central venous pressure (CVP) - Measure central venous oxygen saturation (ScvO2) 7. Remeasure lactate if elevated.

N Engl J Med. 2014 May 1;370(18):1683-93. Over 1500 Patients N Engl J Med. 2014 Oct 16;371(16):1496-506. 1600 Patients

EARLY GOAL DIRECTED THERAPY (EGDT) Both the ProCESS and ARISE trials demonstrated the lack of necessity of using central venous oxygen saturation and central venous pressure monitoring as resuscitation targets when compared to the usual care group.

You say you got a real solution Well, you know We d all love to see the plan Revolution

You ask me for a contribution Well, you know We re all doing what we can Revolution

You tell me it s (for) the institution Revolution

N Engl J Med. 2014 May 1;370(18):1683-93. Over 1500 Patients N Engl J Med. 2014 Oct 16;371(16):1496-506. 1600 Patients

ProCESS ARISE Enrollment Antibiotics Fluids <2 hours from detection of shock 75% received prior to enrollment >2 liters prior ot enrollment 2.8 hours (median) from presentation to ED 70 minutes (median) from presentation to ED 2515ml (mean) prior to enrollment

SSC 2006 six hour bundle SSC 2012 three hour bundle NQF 0500 ProCESS/ARISE/PROMISE NQF 0500 (revised) CMS SEP 1

TO SAVE LIVES... Early identification Early antibiotics Early fluid resuscitation

IMPORTANCE OF REASSESSMENT

CMS SEP-1 Sepsis is a big problem Logic of indicators is good Benchmarked performance

Revolution Don t you know it s gonna be alright, alright, alright

Research / New or Ongoing Clinical Trials

SELEPRESSIN

V1A Receptor Koshimizu, et al. Physiol Rev. 2012 Oct;92(4):1813-64.

LB1148

Gut Integrity in Shock

SSAIL TRIAL (TREATMENT OF SEPTIC SHOCK BY INHIBITING AUTODIGESTION AND PRESERVING GUT INTEGRITY WITH ENTERIC LB1148) LB1148 broad-spectrum serine protease inhibitor delivered enterally to gut Inhibit the intraluminal pancreatic proteolytic enzymes (proteases) that leak due to loss of gut integrity

SOLUBLE THROMBOMODULIN

ANGIOTENSIN II

Chawla, et al. Crit Care. 2014 Oct 6;18(5):534.

POLYMYXIN B HEMOPERFUSION

SOURCES OF ENDOTOXIN Endotoxemia Endotoxin shed from local bacterial infection Endotoxin translocation from GI Tract Every human has 25-30 grams of Endotoxin in their GI tract Less than 0.001 grams of Endotoxin is enough to kill a person

SEPSIS AND ENDOTOXIN Opal SM, et al. Infect Dis, 1999

INTERVENTION DIRECT HEMOPERFUSION WITH ADSORBENT COLUMN USING POLYMYXIN B IMMOBILIZED FIBER BLOOD TUBE Duration: 2 hours FEMORAL or IJ VEIN FEMORAL or IJ VEIN BLOOD PUMP Perfusion rate 80-120 ml/min P ANTICOAGULANT Heparin (3000 U in bolus followed by a continuous infusion of 20 U/kg/h)

HEMODYNAMIC EFFECTS OF PMX Cruz D. et al. Critical Care 2007; 11:R47

JAMA. 2009;301(23):2445-2452

JAMA. 2009;301(23):2445-2452

ENDOTOXIN ACTIVITY ASSAY EAA The only FDA cleared test for detection of Endotoxin

Thank You